Perhaps there are tissue-specific factors (either transcription factors or transcription factor co-activators/co-repressors) that respond differently to 5-aza-dC and TSA, leading to differential induction of MIG-6 and EGR1 in lung cancer and melanoma cells. Here, ERRFI1 is linked to lung cancer.